N/A
N=4,182
Text Reminders to Immunize in a Managed Care Organization
Human Papilloma Virus
Bottom Line
View on ClinicalTrials.gov: NCT01806714 ↗Enrolled (actual)
4,182
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Percentage of Participants Receiving HPV Vaccination (Dose 1) — 16; 13 percentage of eligible participants — p=<0.04
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Text-based reminder for recommended HPV vaccine or WCC (Other); Non-specific text-based reminder (general health tip) (Other)
- Age
- Pediatric, Adult · 11+ yrs
- Sex
- All
- Sponsor
- University of Rochester
- Primary completion
- Dec 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants Receiving HPV Vaccination (Dose 1) |
16; 13 | <0.04 sig |
| SECONDARY Percentage of Participants Receiving HPV Vaccination (Dose 2) |
6; 7 | — |
| SECONDARY Percentage of Participants Receiving HPV Vaccination (Dose 3) |
2; 2 | — |
Summary
The purpose of the study is to evaluate the effectiveness of a managed care-based HPV vaccination reminder/recall system using a randomized controlled trial (RCT) across diverse practices and patient populations. The trial will measure the effectiveness of text messaging reminder/recall on (a) improving initiation and (b) completion rate of the HPV vaccine series; (c) decreasing the time between vaccine doses; and (d) improving rates of preventive visits for adolescents
The hypotheses are that text-messaged reminders to parents of adolescents will result in improved rates of HPV vaccine series initiation, HPV vaccine series completion, will decrease the intervals between vaccine doses and will improve rates of preventive care among adolescents. Parents receiving specific text-messaged reminders about services (i.e. HPV vaccination, well child care visits) for which their adolescent is due will be compared to a control group of parents receiving general health tips through text messages.
Eligibility Criteria
Inclusion Criteria
- 11- 6 months
- Opted in to receive texted reminders from MCO
Exclusion Criteria
Data sourced from ClinicalTrials.gov (NCT01806714). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.